Task · Step 05
Keep the filing valid
Handle changes, the annual report, adverse reactions, recalls and record keeping.
What this step achieves
Purpose: Keep the filing aligned with the real product and with who is responsible, and meet post-market quality and safety duties.
Changes are filed, annual duties are completed on time, and adverse reaction, recall and sales records can be produced on request. Only then does the filing support continued import and sales.
What you must confirm
- Whether the product information has changed
- Whether the annual report was submitted on time
- Whether the filing is still valid
- Whether adverse reaction monitoring and reporting follow the rules
- Whether the recall and sales records are complete
- Whether advertising and e-commerce claims match the filing
How to do it
Decide whether a change is needed
When the product name, formula, manufacturer, label, pack size or domestic responsible person changes, decide first whether a filing change is needed. Key changes should be completed before further import or sale. Provisions on the Administration of Cosmetic Registration and Filing Dossiers
Submit the annual report
Once the filing is a year old, submit the annual report through the filing platform between 1 January and 31 March. It normally covers production and sales, imports, adverse reaction handling and changes.
Run the adverse reaction process
Set up collection, recording, assessment, reporting and control. When a possible adverse reaction appears, first record the batch number, how the product was used, the symptoms, any medical treatment and photos. The domestic responsible person then classifies it as general, serious or a cluster event under the Measures for the Administration of Cosmetic Adverse Reaction Monitoring and reports it through the national system. Do not treat complaints as a public-relations issue only.
Manage recalls
Decide in advance what triggers a recall, who decides, whom to notify, how to control stock and how to record it. When a quality or safety risk appears, assess whether to stop imports, take the product down, notify the channel and recall. If the drug regulator requires risk control or a recall, act within the scope and deadline it sets and keep a full record.
Keep records
Keep filing submissions, raw testing data, the safety assessment process, overseas certificates, translations, change records, import and sales records, and adverse reaction and recall records. They should be available at any inspection.
Required documents
| Document | What it is | Required? |
|---|---|---|
| Change documents | Prepared when a triggering change occurs. | When triggered |
| Annual report | Submitted online in the platform. | When triggered |
| Adverse reaction and recall records | Ongoing post-market duty. | Ongoing |
| Adverse reaction reports | Reported as required. | Ongoing |
| Recall and sales records | Produced at inspection. | Ongoing |
Change documents
When triggeredPrepared when a triggering change occurs.
Annual report
When triggeredSubmitted online in the platform.
Adverse reaction and recall records
OngoingOngoing post-market duty.
Adverse reaction reports
OngoingReported as required.
Recall and sales records
OngoingProduced at inspection.
Watch out for
- Changing the domestic responsible person was simplified by NMPA Announcement No. 70 (2026): the former responsible person consent or a court judgment is no longer needed.
- The annual report window is fixed and short; set a calendar reminder. Build the adverse reaction process before a regulator asks.
- When you change packaging, upgrade a formula, move production or add a shade, decide whether a change is needed before importing more.